Related Experiment Video
Updated: May 1, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Mitral Annular Calcification
Carson Oprysko1, Chinmayi Prabhakar2, Lorin Berman1
1From the Department of Cardiology, Nassau University Medical Center, East Meadow, NY.
Abstract:
Mitral annular calcification (MAC) is a chronic degenerative process strongly associated with aging that predominantly affects the posterior mitral annulus. Its pathogenesis is linked to traditional cardiovascular risk factors that increase mechanical stress and inflammation, promoting pathological cellular differentiation within the annulus. MAC prevalence in the general population is approximately 8-15%, with 8% of affected patients developing clinically significant valvular disease, defined as mitral stenosis or moderate or greater mitral regurgitation. Patients with MAC are at higher risk of cardiovascular mortality and complications, including the development of atrial fibrillation, the development of conduction disorders, and often have signs of coronary or systemic atherosclerosis. Transthoracic echocardiogram remains the first-line imaging modality for the diagnosis of MAC, while cardiac-gated computed tomography is valuable for quantifying severity and progression while also guiding procedural planning. Though management is often conservative, in patients who have clinically significant valvular dysfunction, MAC can present a challenge when planning valvular interventions, and a multidisciplinary approach is often required.
Insights
Mitral annular calcification (MAC), linked to aging and cardiovascular risks, affects 8-15% of people. It increases risks for heart problems and mortality, requiring careful management.
Area of Science:
- Cardiology
- Gerontology
- Medical Imaging
Background:
- Mitral annular calcification (MAC) is a chronic, age-related degenerative process affecting the posterior mitral annulus.
- Pathogenesis involves cardiovascular risk factors, mechanical stress, and inflammation, leading to pathological cellular changes.
- MAC affects 8-15% of the population, with 8% developing significant valvular disease.
Purpose of the Study:
- To review the epidemiology, pathogenesis, clinical significance, and diagnostic modalities of mitral annular calcification.
- To highlight the association of MAC with cardiovascular mortality and complications.
- To discuss the challenges and multidisciplinary approach in managing MAC, especially concerning valvular interventions.
Main Methods:
- Literature review of studies on mitral annular calcification.
- Analysis of epidemiological data and risk factors.
- Evaluation of diagnostic imaging techniques, including echocardiography and cardiac CT.
Main Results:
- MAC is prevalent in 8-15% of the population, increasing with age.
- Patients with MAC face higher risks of cardiovascular mortality, atrial fibrillation, conduction disorders, and atherosclerosis.
- Transthoracic echocardiogram is the primary diagnostic tool; cardiac CT aids in severity quantification and procedural planning.
Conclusions:
- MAC is a significant cardiovascular risk marker associated with adverse outcomes.
- Early diagnosis and risk factor management are crucial.
- A multidisciplinary approach is essential for managing patients with clinically significant MAC, particularly before valvular interventions.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction

